← Eichor
Condition: Low Volume Metastasis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Low Volume Metastasis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT04403867
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic
Phase 3 · 26 location(s) · Nick Beije · NCT07260435
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06347705
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Phase 3 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07241416
A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer
Phase 1 · 2 location(s) · Light Chain Bioscience - Novimmune SA · NCT06663839
A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy a
Phase N/A · 1 location(s) · Bayer · NCT06661122
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
Phase 2 · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06144736
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.